Kelsey Tsai


Kelsey is an Associate of the Blue Venture Fund.

She helps manage the Fund’s investments in Thrive, Lumiata, Onc.AI, Sempre Health, Able To, SonarMD, and Workit Health. Prior to BVF, Kelsey was an MBA associate at ARCH Venture Partners, as well as an Innovation Fund associate for the University of Chicago’s seed stage tech and life sciences fund. Kelsey started her career as a biotech equity research analyst at Morningstar.

Kelsey holds an MBA from the University of Chicago Booth School of Business and a BA in Economics from Georgetown University. She is also a CFA charterholder.